Who would have thought that taking a certain nighttime dose of a popular sleeping pill and driving the next morning do not necessarily mix?
Ileus, or an intestinal blockage, has been added this spring to the list of numerous adverse reactions that have been voluntarily reported by patients taking the antipsychotic Risperdal (risperidone). The FDA approved Risperdal for the treatment of schizophrenia, acute manic or mixed episodes associated with Bipolar I, and irritability associated with autistic disorder.
Fresenius Medical Care North America has recalled 58 lots of its 6.4-liter NaturaLyte Liquid Bicarbonate Concentrate used in dialysis. There were 49 lots in the April 10 recall and another nine in the May 1 expanded recall. The U.S. Food and Drug Administration, which issued its own safety communication on the Fresenius action, elevated the recall May 28 to its most serious level.
Federal regulators are making tanning lamp makers feel the heat. Responding to the increased risk of skin cancer, the U.S. Food and Drug Administration on May 29 reclassified sunlamp products and required warnings on the devices as well as on the materials that market them.
The victims show it. And the juries will know it. Risperdal poses a risk to male children about which allegedly the manufacturer, Janssen Pharmaceuticals, either knew or should have known, and should have adequately warned. Instead the manufacturer marketed the drug to youth and unfortunate outcomes resulted across the nation.
There are plenty of teenage boys who needed the antipsychotic Risperdal. But none of them deserved what the product liability attorneys at Reich & Binstock have seen in their venerable 30-year-old law practice.
Risperdal lawsuits have been filed from Pennsylvania to California and points in between. Many of the victims are young males who developed female-like breasts as a result of using the antipsychotic. The condition is gynecomastia.
It was wrong for a Johnson & Johnson subsidiary to market the antipsychotic Risperdal to youth prior to FDA approval of such use. It was even worse to market the drug devoid of proper warnings about Risperdal and gynecomastia, which is the development of female-like breasts in males.
The prescribing information for the antipsychotic Risperdal has a section titled "Other Adverse Reactions Observed During the Premarketing Evaluation of Risperdal." One of the conditions is gynecomastia, which is the development of female-like breasts in males.
The U.S. Food and Drug Administration has alerted consumers "to rare but serious and potentially life-threatening allergic reactions or severe irritation" that can result from the use of certain over-the-counter acne medications.
Based on its review of 22 reports of serious adverse reactions, including deaths, in 2014, the U.S. Food and Drug Administration is calling for a boxed warning on a prescription drug used to treat teething pain. The children in those reports ranged from 5-months-old to 2 and a half. At the same time, the agency is reiterating its rebuke of the use of over-the-counter topical solutions for the treatment of teething pain.
Heart problems have been linked to the consumption of energy drinks. Victims, or next-of-kin on their behalf, may want to call one of the experienced product liability attorneys at Reich & Binstock for free evaluation of legal options.
The parties involved in hundreds of Risperdal lawsuits will be meeting in conferences scheduled this summer before the Pennsylvania Court of Common Pleas in Philadelphia.
A panel of U.S. Food and Drug Administration experts, who met earlier this month near Washington, will report their findings in regard to the safety of laparoscopic power morcellation. The procedure, according to the FDA, can be used in "hysterectomy or myomectomy in women with uterine fibroids."
Women who have been injured by the transvaginal mesh have been awarded settlements and have received favorable verdicts; nevertheless the opportunity to receive compensation will not last forever. The experienced attorneys at Reich & Binstock offer free consultations to women who used the transvaginal mesh and who suffered any number of serious injuries.
If you were diagnosed with Type-2 diabetes after using the cholesterol-lowering drug Lipitor, there is a chance you are entitled to compensation for your diabetes injury. One way to find out whether there is a case for a Lipitor lawsuit is to get a free consultation from one of the experienced Lipitor attorneys at Reich & Binstock.
On Aug. 15, 2013, there were 53 lawsuits pertaining to four diabetes drugs centralized at the U.S. District Court for the Southern District of California. As of July 15, 463 such lawsuits were pending before that very same court. Many were transferred there by the U.S. Judicial Panel on Multidistrict Litigation, which is the body that establishes multidistrict litigation courts to carry out pretrial management of multiple cases.
Plaintiffs in three GranuFlo lawsuits - two from the U.S. District Court for the Central District of California and one from the Eastern District of Missouri - hope a federal panel in Washington will side with them and not transfer their cases to the federal District of Massachusetts.
Women who were injured as a result of the use of the surgically implanted transvaginal mesh have shown a constellation of ailments. Included in the array, according to the U.S. Food and Drug Administration, are organ perforation and mesh erosion through the vagina. There are reports of infection and bleeding as well as urinary and neuro-muscular problems. All of this is very painful, and the road to relief often leads to surgery.
The Journal of Clinical Psychopharmacology in April 2006 published an article that connected the dots between the use of the antipsychotic risperidone, the brand name of which is Risperdal, and a condition seen in adolescents known as gynecomastia or the development of female-like breasts in males.
Back in January, the U.S. Food and Drug Administration updated its safety advisories in regard to the anti-cholesterol drug Lipitor and other so-called "statin" drugs. It read, "People being treated with statins may have an increased risk of raised blood sugar levels and the development of Type 2 diabetes."
The U.S. Food and Drug Administration in July issued labeling changes for dozens of drugs. The antidepressant Zoloft (sertraline hydrochloride) made the list.
Lawsuits have been filed. Equipment has been withdrawn from the market. The U.S. Food and Drug Administration put out safety alerts. And, now, U.S. senators have called for a swift and stern regulatory response. All of these developments pertain to the use of the laparoscopic power morcellator.
A new study released Aug. 19 in the Annals of Internal Medicine showed that risperidone, the generic version of the antipsychotic Risperdal, and two other drugs in its class have been linked to a higher risk for acute kidney injury, or AKI, in older patients being treated for behavioral symptoms of dementia.
Three Texas plaintiffs and one Alabama defendant will find out in October from a panel of judges whether their federal testosterone replacement therapy lawsuits will be transferred to U.S. District Court for the Northern District of Illinois. Going on 200 federal cases are already there. Plaintiffs or their surviving next-of-kin claim testosterone replacement therapy led to serious injury, which proved fatal in some cases.